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Abstract 
The work evaluated the activity of reduced and conventional doses of luteolytic substances on both clinical 
and reproductive parameters of mares. Females received intramuscularly, 125 μg (n = 20) and 250 μg (n = 20) 
of Cloprostenol or 2.5 mg (n = 20) and 5.0 mg (n = 20) of Dinoprost. The rectal temperature and both heart 
and respiratory frequencies were assessed before and after administration of such luteolytics, considering the 
occurrence of sweating, diarrhea, colic, and prostration. Estrus detection and follicular development were 
monitored daily until ovulation, when artificial insemination (AI) was performed. Pregnancy was diagnosed 
on day 30 and confirmed on day 60. Only mares treated with 2.5 and 5.0 mg of Dinoprost showed alterations 
(P < 0.05) of respiratory frequency, while the remaining parameters were not altered (P > 0.05). The sweating 
occurred in 5% and 10% of treated mares, respectively, with 2.5 mg and 5.0 mg of Dinoprost and diarrhea in 
only 5% of those that received 5.0 mg of this luteolytic. Both estrus and pregnancy rates in treated mares with 
125 μg of Cloprostenol (45%/35%) and 2.5 mg of Dinoprost (50%/30%) were lower than (P < 0.05) those that 
received 250 μg of Cloprostenol (85%/70%) and 5 mg of Dinoprost (90%/75%). Both estrus and pregnancy 
rates in control mares were lower (P < 0.05) than their treated counterparts. In conclusion, although not 
promoting significant clinical alterations, reduced doses of luteolytics did not display the same efficiency of 
conventional doses to induce estrus in mares. 
Keywords: equine; prostaglandin; side effect; estrus. 
 
Resumo 
Avaliou-se a ação de doses reduzidas e convencionais de substâncias luteolíticas sobre parâmetros clínicos e 
reprodutivos de éguas. As femeas receberam intramuscularmente, 125 μg (n = 20) e 250 μg (n = 20) de 
Cloprostenol e 2.5 mg (n = 20) e 5.0 mg (n = 20) de Dinoprost. A temperatura retal e as frequências cardíaca 
e respiratória foram aferidas antes e após a administração desses luteolíticos, considerando-se ainda a 
ocorrência de sudorese, diarreia, cólica e prostração. Monitorou-se o estro e o desenvolvimento folicular até a 
ovulação, quando realizou-se a inseminção artificial. A gestação foi diagnosticada com 300 e confirmada no 
60o dia. Apenas as éguas tratadas com 2,5 e 5,0 mg de Dinoprost apresentaram alteração (P < 0.05) da 
frequência respiratória e os demais parâmetros não foram alterados (P > 0.05). A sudorese ocorreu em 5% e 
10% das éguas tratadas, respectivamente, com 2.5 mg e 5.0 mg de Dinoprost e a diarréia em apenas 5% 
daquelas que receberam 5.0 mg desse luteolítico. As porcentagens de estro e prenhez das éguas tratadas com 
125 μg de Cloprostenol (45%/35%) e 2.5 mg de Dinoprost (50%/30%) foram menores (P < 0.05) do que os 
daquelas que receberam 250 μg de Cloprostenol (85%/70%) e 5 mg de Dinoprost (90%/75%). O estro e a 
prenhez das éguas Controle foram menores (P < 0.05) do que nas tratadas. Conclui-se que apesar de não 
promoverem alterações significativas dos parâmetros clínicos, as doses reduzidas não apresentam as mesmas 
eficiências dos tratamentos com doses convencionais para induzir o estro. 
Palavras-Chave: equino; prostaglandina; efeito colateral; estro. 
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Introdução 
Prostaglandins are long chain fatty acids that 
play similar roles to hormones in several tissues 
during both physiological and pathological 
processes (Smith and Manson, 1974; Coffman and 
Pinto, 2016). In reproduction, these substances are 
normally used to induce luteolysis (Newcombe et 
al., 2008) and uterine contractions, in order to 
induce delivery or pregnancy loss (Noden et al., 
1978; Ousey et al., 1984; Brendemuehl, 2002; 
Ladim Alvarenga et al., 2006). 
Prostaglandins can be used on clinical 
approaches to endometritis treatment (Faria and 
Gradela, 2010) and mostly in assisted reproduction 
programs, such as artificial insemination (AI) and 
embryo transfer (ET), that require perfect 
synchrony of estrus and ovulation between donor 
and recipient mares (Taveiros et al., 2003/2008; 
Rabelo et al., 2009). In general, the response to 
treatment with luteolytic agents is conditioned to 
the phase of the estrous cycle (Azevedo et al., 
2014/2015). 
Although the results described in horses 
remain conflicting, this treatment should be 
performed within days 5 and 16 post-ovulation 
(Squires, 2008). The usage of luteolytic agents 
before day 7 post-ovulation, may result in the 
development of hemorrhagic and anovulatory 
follicles in the following estrous cycles, 
compromising the fertility of the mare (Ginther et 
al., 2007/2008; Cuervo-Arango and Newcombe, 
2009/2010; Leal Fonseca et al., 2016).  
Prostaglandins may also promote side 
effects in other systems, thus inducing alterations 
in thermoregulation, sweating, tachycardia, 
abdominal distress, motor incoordination, 
prostration and, in extreme cases, anaphylaxis and 
chemotaxis (Allen et al., 1974; Miller et al., 1976; 
Nelson, 1976; Goyings et al., 1977; Faria and 
Gradela, 2010; Kuhl et al., 2016ab). Alternatively, 
the development of prostaglandin synthetic analogs 
with increased biological activity and greater 
specificity toward the reproductive tract has led to 
lower side effects (Cuervo-Arango and 
Newcombe, 2012; Kuhl et al., 2016ab).  
In order to minimize such side effects, the 
evaluation of physiological parameters, possibly 
influenced by prostaglandins and its synthetic 
analogs, continues as an up-to-date research topic 
and important to be taken into account (Evans et 
al., 2007; Silva et al., 2015), specially in the 
Northeast of Brazil, where limited information is 
available about the subject. Under such conditions,  
the work was aimed to evaluate the effect of 
reduced doses of Cloprostenol or Dinoprost on the 
heart rate, respiratory rate, and rectal temperature, 
while monitoring for sweating, diarrhea, colic, and 
prostration, but also the estrus induction efficiency 
and pregnancy thereafter.  
 
Material and Methods 
The experiment was conducted in Limoeiro, 
Pernambuco State, Brazil. The farm is in a region 
of tropical sub-humid weather and is located 
following the geographic coordinates 7o 52’ 29’’ S 
latitude and 35o 27’ 01’’ W longitude. The mean 
annual temperature is 24 oC and mean rainfall of 
1,248 mm3. 
Donor and recipient mares were non-
lactating and of the Mangalarga Machador breed, 
with age from 5 to 15 years and live weight from 
450 to 550Kg. Mares were subject to semi-
extensive management practices and maintained in 
cultivated pastures (Digitaria decumbes) and 
access to water and mineralized salt (Suprafós 73, 
Supranor®) ad libitum. Moreover, mares were also 
supplemented with Tifton (Cynodon spp), Alfalfa 
(Medicago sativa), and 4 kg of commercial horse 
food (Corcelina®, Purina). 
Mare selection was performed by body 
condition score that varied from 5 to 7 in an 1 to 9 
scale, according to Henneke et al. (1983) and 
cyclicity condition. The selection also considered 
the analysis of reproductive performance and both 
clinical and gynecological examinations. The later 
was performed using ultrassound (Aquila Pro - 
Esaote) equipped with a linear multi frequential 
linear transducer (6 and 8 MHz) in order to identify 
the presence of uterine fluid and endometrial 
alterations that may affect fertility, as suggested by 
Taveiros et al. (2008). 
Mares were used in the experiment when 
found in the diestrous phase, between days 8 and 
10 post-ovulation were treated with different doses 
of luteolytic agents by an intramuscular (IM) shot. 
A group of mares (n = 40) received D-Cloprostenol 
(Ciosin®, MSD Saúde Animal) in 125 μg (n = 20) 
and 250 μg (n = 20) doses. Alternatively, mares (n 
= 40) were subject to Dinoprost Tromethamine 
(Lutalyse®, Pfizer) treatment with 2.5 mg (n = 20) 
or 5.0 mg (n = 20) doses. Mares of the Control 
group (n = 20) were subject to an 2 mL saline 
solution (Soro Fisiológico, Farmace®) dose, also by 
an IM shot.  
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After treatment with these luteolytic agents, 
mares were scored for rectal temperature (oC) and 
both heart (bpm) and respiratory (mpm) 
frequencies as described by Silva et al. (2015), five 
minutes before and fifteen minutes after the 
administration of the luteolytic agent. Mares were 
also monitored for sweating within inital 60 
minutes after treatment, and also for diarrhea, colic, 
and prostration up to 24 hours post-administration 
of the luteolytic agent. During the evaluation of 
these later clinical parameters, data was collected 
as present or absent.  
Mares were also observed daily for estrus 
detection. The estrus was scored as induced those 
that were observed within initial five days (120 
hours) post-administration of the luteolytic agent. 
After estrus detection, follicular development was 
monitored by ultrasonography at 12-hour intervals 
until ovulation. 
After detection of ovulation, AI was 
performed using freshly collected semen with a 
dose of 500 x 106 sperm cells from stallions of 
proven fertility. Pregnancy diagnosis was 
performed by rectal palpation accompanied by 
ultrasonography on day 30 and later confirmed on 
day 60 post-AI. 
The data was initially subject to the Shapiro-
Wilks normality test. The data with normal 
distribution was further subject to ANOVA for 
comparisons among groups, while paired T test 
was used for comparisons between time-points 
inside groups. The binomial data was scored as 
percentages and inferred by the chi-square test with 
the Yates correction factor (Preacher, 2001).  
 
The significance level was 5% for all analysis.  
 
Results 
Table 1 displays the clinical findings 
concerning the presence or absence of sweating, 
diarrhea, colic, and prostration in mares treated 
with luteolytic agents. Only mares treated with 
Dinoprost showed increased sweating during initial 
20 minutes after treatment, while 5% (1/20) were 
those from 2.5 mg dose and 10% (2/20) of mares 
treated with 5.0 mg of Dinoprost. Diarrhea was 
found in 5% (1/20) mares treated with 5.0 mg of 
this luteolytic agent. 
Table 2 holds the mean values for rectal 
temperature, heart frequency, and respiratory 
frequency obtained before (5 minutes) and after (15 
minutes) treatment with Cloprostenol and 
Dinoprost, under both reduced and conventional 
doses. Only mares treated with 2.5 or 5.0 mg 
Dinoprost doses showed alterations (P < 0.05) of 
respiratory frequency. The other parameters were 
not influenced (P > 0.05) by such treatments. 
Figure 1 shows that reduced doses of both 
Cloprostenol and Dinoprost were less efficient (P < 
0.05) than conventional doses to induce estrus 
(respectively, 9/20 and 10/20; 17/20 and 18/20), 
was more efficient (P < 0.05) than obtained in 
control mares (3/20). Similarly, pregnancy rates in 
mares treated with reduced doses (respectively, 
7/20 and 6/20) was lower (P < 0.05) than those in 
mares that received conventional doses 
(respectively, 14/20 and 15/20) and was not more 
efficient (P > 0.05) than the pregnancy rate 
obtained in control mares (2/20). 
 
 
Table 1. Clinical findings related to sweating, diarrhea, colic, and prostration within initial 24 hours in mares treated with 
Cloprostenol and Dinoprost. 
Group 
Clinical Findings 
Sweating Diarrhea Colic Prostration 
Cloprostenol 125 Absent Absent Absent Absent 
Cloprostenol 250 Absent Absent Absent Absent 
Dinoprost 2.5 Present Absent Absent Absent 
Dinoprost 5.0 Present Present Absent Absent 
Control Absent Absent Absent Absent 
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Table 2. Mean and standard deviation ( ± SD) for rectal temperature, heart and respiratory frequencies in Manga Larga 
Marchador mares before (5 minutes) and after (15 minutes) treatment with different doses of Cloprostenol (μg) 
or Dinoprost (mg). 
 
 
 
 
Group 
Physiological Parameters 
Rectal Temperature 
(0C) 
Heart Frequency 
(bpm) 
Respiratory Frequency 
(mrm) 
Before 
± SD 
After 
± SD 
Before 
± SD 
After 
± SD 
Before 
± SD 
After 
± SD 
Cloprostenol 125 38.4±0.2 38.4±0.2 49.9±6.6 51,7±5.5 27.4±2.9 27.8±2.5 
Cloprostenol 250 38.4±.0.2 38.4±0.2 51.6±4.5 52,0±3.9 27.3±2.5  28.1±2,6 
Dinoprost 2.5 38.3±0.20 38.3±0.2 53.8±5.2 53.6±4.8 26.8±2.6a 29.2±2.7b 
Dinoprost 5.0 38.4±0.2 38.4±0.2 51.3±4.8 52.2±4.8 27.5±1.9a 29.6±2.1b 
Control 38,4±0,2 38.4±0.2 49.8±6,6 50.4±8.0 27.1±2.9 27.8±2.5 
 
 
 
Figure 1. Estrus and pregnancy rates in Manga Larga Marchador mares subject to reduced and convetional 
doses of Cloprostenol (μg) and Dinoprost (mg) treatments. Different letters, uppercase (estrus) 
or lowercase (pregnancy), indicate statistical difference (P < 0.05) among groups. 
 
 
Discussion 
The side effects occur after administration of 
conventional doses of luteolytic agents in 10% to 
40% of mares treated with prostaglandin, thus 
being commonly observed sweating, diarrhea, 
tachycardia, and colic-resembling signs (Miller et 
al.; 1976; Irvine et al., 2002; Faria and Gradela, 
2010; Coffman and Pinto, 2016). In this study, 
sweating was triggered by Dinoprost treatment, 
irrespectively of the dose used. This clinical 
alteration was expected with the conventional dose, 
but not with the reduced one, since both the 
manufacturer and some authors highlight about this 
possibility (Miller et al.; 1976; Irvine et al., 2002; 
Faria and Gradela, 2010; Coffman and Pinto, 
2016). 
The sweating can be due to cutaneous 
vasodilatation induced by prostaglandins, as 
demonstrated both in humans (McCord et al., 
2006) and animals (Faria and Gradela, 2010; 
Coffman and Pinto, 2016; Kuhl et al., 
2016ab/2017). In horses, this clinical sign is due to 
adrenoreceptor stimulation of sudoriparous gland 
cells, determined by a significant increase in 
adrenalin and noradrenalin concentrations after 
prostaglandin administration (Jenkinson et al., 
2006/2007). In general, sweating gradually 
increases due to increasing doses (Miller et al., 
1976; Irvine et al., 2002; Kuhl et al., 
2016ab). Mares treated with Cloprostenol did not 
display sweating, a fact that was expected due to its 
greater specificity over the reproductive tract, that 
ultimately leads to reduced side effects (Cuervo-
Arango and Newcombe, 2012; Kuhl et al., 
2016ab/2017).  
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As described above, the percentage of mares 
displaying sweating was low in comparison to 
results described by other authors (Faria and 
Gadelha, 2010; Coffman and Pinto, 2016). This 
finding can be attributed to the location where the 
experiment was conducted, under tropical sub-
humid conditions and mild mean annual 
temperature. According to Kuhl et al. (2016a), 
excessive sweating is more perceptible in mares 
subject to warm and humid environments, where 
air humidity saturation occurs more easily, even 
using prostaglandin analogs.  
Some mares in this study showed diarrhea 
after treatment with the conventional dose of 
Dinoprost. This clinical sign, according to 
Alcántara et al.  (2005 ) and Kuhl et al. (2016a), 
occurs in a high percentage of mares treated with 
the natural form of the prostaglandin or even with 
some synthetic analogs, irrespectively of the dose 
used. The effect of prostaglandins on fecal 
consistency was also reported in humans and may 
be caused by direct stimulation of intestinal smooth 
muscle (Horton and Main, 1963; Horton et al., 
1968). According to Kuhl et al. (2016ab), an 
indirect and alternative effect of prostaglandins on 
the gastrointestinal function that should be taken 
into account is the release of cortisol. In this study, 
no clinical sign was observed that could be 
suggestive of any abdominal pain or colic 
development. However, according to Coffman and 
Pinto (2016), prostaglandin administration may 
cause hipergastromotility, while some mares may 
display colic or colic-like symptoms.   
The rectal temperature was not affected by 
different doses administered and neither due to the 
luteolytic agent used since Dinoprost and 
Cloprostenol did not exert any influence on the 
rectal temperature. Contrary to these findings, Kuhl 
et al. (2016ab) found a significant decrease in rectal 
temperature after administration of prostaglandin 
synthetic analogs. Miller et al. (1976) describes this 
phenomenon as a response to sweating and must be 
interpreted as a thermoregulation mechanism. 
Since sweating was rather discreet and in few 
mares, as described above, this effect may not have 
reached a magnitude to affect the rectal 
temperature. 
Although some authors found an increase in 
heart frequency, in a dose-dependent manner 
(Miller et al., 1976; Nie et al., 2001; Irvine et al., 
2002), the absence of heart frequency alterations in 
response to Cloprostenol and Dinoprost  
administrations, as described above, are in 
agreement with findings by Alcántara et al. (2005). 
In contrast, the respiratory frequency was altered 
by both doses of Dinoprost, in agreement with Nie 
et al. (2001) who found similar alterations with 
treatment with both Dinoprost and Cloprostenol. A 
possible explanation for this fact described above 
is that prostaglandin acts a bronchoconstrictor 
factor (Kirschvink et al., 2001), thus lowering the 
respiratory capacity of the animal and leading to 
increases in the respiratory frequency as a 
compensation mechanism. 
The estrus induction by both luteolytic 
agents was considered very promising since most 
mares responded to treatment within a period of 
five days, especially with conventional doses. This 
result was initially credited to the fact that mares 
displayed normal cyclicity before the experiment 
and thereafter due to the fact that, at the time-point 
of treatment with luteolytic agents, mares were in 
the diestrous phase. Therefore, mares were found 
in the receptive period for the activity of luteolytic 
agents, as previously reported by Weber et al. 
(2001), Kotwica et al. (2002), and Kuhl et al. 
(2016ab).  
The body condition score, the cyclicality 
status, and known reproductive performance may 
have contributed to pregnancy in mares with 
induced estrus, which were similar to those found 
by Cuervo-Arango and Newcombe (2010), Metcalf 
and Thompson (2010), and Leal Fonseca et al. 
(2016). Moreover, it is an interesting fact to outline 
that the number satisfactory of pregnant mares may 
have also been due to follicular growth control  that 
allowed the AI to be performed immediately after 
ovulation. It is also important to consider that the 
number of pregnant mares during this five-day 
period was greater than those from the control, a 
fact that eases management practices and further 
minimizes production costs with trained personnel. 
 
Conclusion 
The results allow the conclusion that, 
although not promoting significant clinical 
alterations, reduced doses of luteolytic agents did 
not display the same efficiency of conventional 
doses to induce estrus in mares. 
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